These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35927519)

  • 41. [Efficacy and safety of intravenous immunoglobulins in the management of neonatal hyperbilirubinemia due to ABO incompatibility: a meta-analysis].
    Cortey A; Elzaabi M; Waegemans T; Roch B; Aujard Y
    Arch Pediatr; 2014 Sep; 21(9):976-83. PubMed ID: 25125032
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neonatal management and outcome in alloimmune hemolytic disease.
    Ree IMC; Smits-Wintjens VEHJ; van der Bom JG; van Klink JMM; Oepkes D; Lopriore E
    Expert Rev Hematol; 2017 Jul; 10(7):607-616. PubMed ID: 28503958
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more.
    Newman TB; Liljestrand P; Jeremy RJ; Ferriero DM; Wu YW; Hudes ES; Escobar GJ;
    N Engl J Med; 2006 May; 354(18):1889-900. PubMed ID: 16672700
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hyperbilirubinemia and bilirubin toxicity in the late preterm infant.
    Watchko JF
    Clin Perinatol; 2006 Dec; 33(4):839-52; abstract ix. PubMed ID: 17148008
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cochrane Review: Prophylactic phototherapy for preventing jaundice in preterm or low birth weight infants.
    Okwundu CI; Okoromah CA; Shah PS
    Evid Based Child Health; 2013 Jan; 8(1):204-49. PubMed ID: 23878128
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Meta analysis of the effect of immunoglobulin infusion on neonatal isoimmune hemolytic disease caused by blood group incompatibility].
    Li ZH; Wang J; Chen C
    Zhonghua Er Ke Za Zhi; 2010 Sep; 48(9):656-60. PubMed ID: 21092522
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sn-Mesoporphyrin interdiction of severe hyperbilirubinemia in Jehovah's Witness newborns as an alternative to exchange transfusion.
    Kappas A; Drummond GS; Munson DP; Marshall JR
    Pediatrics; 2001 Dec; 108(6):1374-7. PubMed ID: 11731664
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Screening and early postnatal management strategies to prevent hazardous hyperbilirubinemia in newborns of 35 or more weeks of gestation.
    Maisels MJ
    Semin Fetal Neonatal Med; 2010 Jun; 15(3):129-35. PubMed ID: 20034861
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intensive phototherapy vs. exchange transfusion for the treatment of neonatal hyperbilirubinemia: a multicenter retrospective cohort study.
    Zhang M; He Y; Tang J; Dong W; Zhang Y; Zhang B; Wan H; Deng Q; Guan L; Xia B; Chen Z; Ge M; Zhao J; Li W; Pei J; Qu Y; Mu D
    Chin Med J (Engl); 2022 Feb; 135(5):598-605. PubMed ID: 35274627
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [An update on unconjugated neonatal hyperbilirubinaemia in Denmark].
    Donneborg ML; Hansen BM; Petersen JP; Vandborg PK; Ebbesen F
    Ugeskr Laeger; 2020 Mar; 182(14A):. PubMed ID: 32285792
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hyperbilirubinemia in the newborn infant > or =35 weeks' gestation: an update with clarifications.
    Maisels MJ; Bhutani VK; Bogen D; Newman TB; Stark AR; Watchko JF
    Pediatrics; 2009 Oct; 124(4):1193-8. PubMed ID: 19786452
    [No Abstract]   [Full Text] [Related]  

  • 52. Neonatal hyperbilirubinemia: recommendations for diagnosis and management in the emergency department.
    Khan A; Kim TY
    Pediatr Emerg Med Pract; 2022 Jan; 19(1):1-24. PubMed ID: 34919365
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacological therapies for unconjugated hyperbilirubinemia.
    Cuperus FJ; Hafkamp AM; Hulzebos CV; Verkade HJ
    Curr Pharm Des; 2009; 15(25):2927-38. PubMed ID: 19754369
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.
    Miqdad AM; Abdelbasit OB; Shaheed MM; Seidahmed MZ; Abomelha AM; Arcala OP
    J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Severe hyperbilirubinaemia and kernicterus: more caution is needed in newborn jaundice surveillance.
    Allen NM; Mohammad F; Foran A; Corcoran D; Clarke T
    Ir Med J; 2009; 102(7):228-9. PubMed ID: 19772008
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessing jaundice in infants of 35-week gestation and greater.
    Lease M; Whalen B
    Curr Opin Pediatr; 2010 Jun; 22(3):352-65. PubMed ID: 20463489
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Are recommended phototherapy thresholds safe enough for extremely low birth weight (ELBW) infants? A report on 2 ELBW infants with kernicterus despite only moderate hyperbilirubinemia.
    Moll M; Goelz R; Naegele T; Wilke M; Poets CF
    Neonatology; 2011; 99(2):90-4. PubMed ID: 20639681
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intravenous Immunoglobulins as Adjunct Treatment to Phototherapy in Isoimmune Hemolytic Disease of the Newborn: A Retrospective Case-Control Study.
    Al-Lawama M; Badran E; Elrimawi A; Bani Mustafa A; Alkhatib H
    J Clin Med Res; 2019 Nov; 11(11):760-763. PubMed ID: 31803318
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Trends in hospitalizations for neonatal jaundice and kernicterus in the United States, 1988-2005.
    Burke BL; Robbins JM; Bird TM; Hobbs CA; Nesmith C; Tilford JM
    Pediatrics; 2009 Feb; 123(2):524-32. PubMed ID: 19171618
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Screening of infants for hyperbilirubinemia to prevent chronic bilirubin encephalopathy: US Preventive Services Task Force recommendation statement.
    US Preventive Services Task Force
    Pediatrics; 2009 Oct; 124(4):1172-7. PubMed ID: 19786451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.